Supported by
SynthBox enables scientists to create DNA in-house, same day.
Synthetic DNA on-demand, when you need it.
Create DNA in hours, not weeks. Synthesise any conceivable DNA sequence, with vectors, on demand.
Customize and adapt your system to your liking. Components designed for limitless modularity.
Designed for no-effort DNA synthesis. No proprietary limitations or vendor lock-in.
DNA synthesis is the engine behind today's breakthroughs.
Print custom DNA to design and test therapies faster.
Generate templates for proteins and synthesise them through recombinant means.
Build new pathways for sustainable chemicals and fuels.
Rapidly create probes and primers for faster, sharper testing.
Prototype and validate therapeutic constructs in-house.
Engineer crops with improved traits and resilience.
Press Release — January 2026
AmpliSynth is pioneering same-day, kitless DNA synthesis with SynthBox—a revolutionary platform that brings industrial-grade DNA production directly into research labs.
Unlike traditional outsourced synthesis that takes weeks and relies on proprietary kits, SynthBox delivers fully automated, open-system DNA production in hours. Researchers can now synthesize custom sequences with vectors on-demand, eliminating bottlenecks in drug discovery, synthetic biology, and gene therapy workflows.
Built on cutting-edge DNA printing technology developed by industry pioneers, SynthBox represents the convergence of 3D printing precision with molecular biology. Our modular, vendor-neutral approach ensures laboratories maintain full control over their synthesis pipeline without lock-in.
Learn more about SynthBox →
By joining our waitlist, you'll be the first to know when we launch—no spam, just early access, updates, and exclusive perks reserved for our earliest supporters.
Pop your name and email with the request and I'll be happy to send our non-confidential overview deck.
